Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3062]
News [6217]
Articles [124]
Editorials [18]
Conferences [183]
elearning [32]
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin...
Dr Merry-Jennifer Markham - University of Florida, Florida, USA
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis ( Dr Merry-Jennifer Markham - University of Florida, Florida, USA )
30 May 2015
Novel JAK inhibitor pacritinib proving effective for easing symptoms of...
Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA
Novel JAK inhibitor pacritinib proving effective for easing symptoms of myelofibrosis ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )
30 May 2015
Novel JAK inhibitor pacritinib proves effective for easing symptoms of...
Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA
Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )
30 May 2015
Nivolumab shows highly promising activity in advanced liver cancer in early...
Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive...
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )
29 May 2015
Certain classes of genes in patients that could lead to prostate cancer
Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
Certain classes of genes in patients that could lead to prostate cancer ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
1 May 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant...
Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015
Investigational PD-L1–targeted immunotherapy safe for patients with triple...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
1 May 2015
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 May 2015
What are the objectives for CART-meso immunotherapy?
Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA
What are the objectives for CART-meso immunotherapy? ( Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA )
30 Apr 2015
How will genomics be applied to patient therapy in future?
Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant...
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Apr 2015
Inside cancer - public lecture
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Inside cancer - public lecture ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
29 Apr 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation